Skip to main content

The Significance of Several Coagulation Tests in the Evaluation of the Risk of Bleeding

  • Chapter

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 9))

Abstract

Coagulation tests are widely used in liver diseases in the evaluation of hepatic insufficiency. They are obligatory in the assessment of the risk of bleeding in patients submitted to surgical procedures such as liver biopsy, minor or major surgery.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aoki M, Yairanak T. 1978. α2-plasmin inhibitor levels in liver diseases. Clin. Chimi. Acta, 84, 99–105.

    Article  CAS  Google Scholar 

  2. Bick RL. 1983. Disseminated intravascular coagulation and related syndromes. In: Alterations of hemostasis in chronic liver diseases. RCR Press Inc. Baca Raton, Florida, 121–125.

    Google Scholar 

  3. Brozovic M. 1982. Pathogenesis of haemostatic abnormalities in liver diseases. In : Haemostasis and Thrombosis, Blom A, Thomas D. Eds. Churchill Livinstone, 422–428.

    Google Scholar 

  4. Conard J, Certin K, Samama M, Opolon P. 1975. Les troubles de la coagulation au cours des cirrhoses, et leur traitement. J. Franç. Gastro-Ent. Masson Ed., Paris, 188–203.

    Google Scholar 

  5. Couinaud C. 1979. Action de la splénectomie sur les troubles plaquettaires des cirrhotiques. Chirur. 105, 380–383.

    CAS  Google Scholar 

  6. Couinaud C. 1980. Introduction à l’étude de l’hémostase chez le cirrhotique. Sem. Hôp. Paris 29(32), 1323–1329.

    Google Scholar 

  7. Forestier F, Boisson J., Samama M. 1975. Contre-indications de la ponction biopsie hépatique. Sem. Hôp. Paris 51(46), 2815–2817.

    PubMed  Google Scholar 

  8. Francis JL, Armstrong DJ. 1982. Acquired dysfibrinogenemia in liver disease. J. Clin. Pathol. 35, 667–672.

    Article  PubMed  CAS  Google Scholar 

  9. Guillin MC, Menache D, Barge D, Rueff B, Fauvert R, Curé R, Dosse J, Lorin J. 1971. Les troubles de l’hémostase au cours des hépatites virales graves. Etude clinique, anatomioue et biologioue. Ann. Med. Intern. 122(5), 605–612.

    CAS  Google Scholar 

  10. Larrieu HJ. 1976. Les troubles de l’hémostase et de la coagulation chez les cirrhotiques. Revue Prat. 26(51), 3651–3657.

    CAS  Google Scholar 

  11. Lechner K, Niesser H, Thaler E. 1977. Coagulation abnormalities in liver disease. Semin. Thromb. Faemostas. 4, 422–428.

    Google Scholar 

  12. Lurie E, Creter D. 1981. Coagulation studies for severe liver disease detection in a gastro-enterologie department. Digestion 21, 244–247.

    Article  PubMed  CAS  Google Scholar 

  13. Mannucci P, Mari D. 1981. Haemostasis and liver disease. Hematologica 66(2), 233–248.

    CAS  Google Scholar 

  14. Marchal G, Samama M, Prost RJ. 1960. Etude de la coagulation et de l’hémostase dans 74 cas de cirrhoses. Sang 8 XXXI, 704–715.

    Google Scholar 

  15. Nilsson UVI. 1964. Coagulation studies in liver disease. Thrombos. Diathes. Kaemorrh. 11, 51–53.

    Google Scholar 

  16. Rajni MU, Lewis JH, Spero JA, Hasiba U. 1982. Bleeding and coagulation abnormalities in alcohol cirrhosis liver disease. Alcoholism : Clinical Experimental Research 6(2), 267–274.

    Article  Google Scholar 

  17. Saito H, Goodnough LT, Boyle JM, Heimburger N. 1981. Reduced Eistidin Rich Glycoprotein levels in plasma of patients with advanced liver cirrhosis. Amer. J. Med. 73, 179–182.

    Article  Google Scholar 

  18. Samama M, Soria C, Soria J. 1970. Dysfibrinogénémies acquises. Nouv. Revue Franç. Hématol. 10(5), 666–669.

    Google Scholar 

  19. Samama M, Schlegel N., Cazenave B, Horellou MH, Conard J, Castel M, Douenias R. α2-antiplasmin assay: amidolytic and immunological method. Critical evaluation. Results in a clinical material. In: Synthetic Substrates in Clinical Blood Coagulation Assays. Lijnen HR, Collen D, Verstraete M. Eds., 93–98.

    Google Scholar 

  20. Soria J, Soria C, Ryckewaert JJ, Samama M, Thomson JM, Poller L. 1980. Study of acquired dysfibrinogenemia in liver disease. Thrombos Res. 19, 29–41.

    Article  CAS  Google Scholar 

  21. Stein SF, Harker LA. 1982. Kinetic and functional studies of platelets fibrinogen and plasminogen in patients with hepatic cirrhosis. J. Lab. Clin. Med. 99, 217–230.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Samama, M. (1984). The Significance of Several Coagulation Tests in the Evaluation of the Risk of Bleeding. In: Fondu, P., Thijs, O. (eds) Haemostatic Failure in Liver Disease. Developments in Hematology and Immunology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6006-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6006-0_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6008-4

  • Online ISBN: 978-94-009-6006-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics